Viewing Study NCT07420257


Ignite Creation Date: 2026-03-26 @ 3:16 PM
Ignite Modification Date: 2026-03-30 @ 2:13 AM
Study NCT ID: NCT07420257
Status: NOT_YET_RECRUITING
Last Update Posted: 2026-02-19
First Post: 2026-02-12
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Randomized, Double-blind, Placebo-controlled Phase III Study to Evaluate the Efficacy and Safety of CM326 in Participants With Chronic Rhinosinusitis With Nasal Polyposis
Sponsor: CSPC Baike (Shandong) Biopharmaceutical Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module